|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|
| Operating activities: | ||
| Net loss | ||
| Adjustments to reconcile net loss to net cash used in operating activities: | ||
| Depreciation | ||
| Noncash operating lease expense | ||
| Restructuring and impairment charges | ||
| Stock-based compensation expense | ||
| Amortization of deferred commissions | ||
| Foreign currency remeasurement loss (gain) | ||
| Change in fair value of redeemable convertible preferred stock warrant liability | ||
| Change in fair value of preferred stock tranche option liability | ||
| Amortization of premium / discount on short-term investments | ||
| Other | ||
| Changes in operating assets and liabilities: | ||
| Deferred commissions | ||
| Accounts receivable | ||
| Contract and other non-current assets | ||
| Prepaid expenses and other current assets | ||
| Operating lease liabilities | ||
| Accounts payable | ||
| Accrued expenses and other liabilities | ||
| Deferred revenue | ||
| Net cash used in operating activities | ||
| Investing activities: | ||
| Purchases of property and equipment | ||
| Purchases of short-term investments | ||
| Maturities of short-term investments | ||
| Sales of short-term investments | ||
| Net cash provided by (used in) investing activities | ||
| Financing activities: | ||
| Proceeds from initial public offering, net of underwriting discounts and commissions | ||
| Payment of stock offering costs | ||
| Proceeds from exercises of employee stock options | ||
| Proceeds from issuance of common stock under employee stock purchase plan | ||
| Proceeds from issuance of redeemable convertible preferred stock | ||
| Redeemable convertible preferred stock issuance costs | ||
| Employee payroll taxes paid for net shares settlement of restricted stock units | ||
| Repurchase of common stock from employees | ||
| Proceeds from issuance of debt, net of issuance costs | ||
| Principal repayments on debt | ||
| Net cash provided by financing activities | ||
| Effect of exchange rates on cash and cash equivalents and restricted cash | ||
| Net increase in cash, cash equivalents and restricted cash | ||
| Cash, cash equivalents and restricted cash, beginning of year | ||
| Cash, cash equivalents and restricted cash, end of period | ||
| Supplementary cash flow disclosure: | ||
| Short-term investments, end of period | ||
| Cash paid for interest | ||
| Cash paid for income taxes | ||
| Deferred offering costs accrued but not yet paid | ||
| Conversion of redeemable convertible preferred stock to common stock (Note 12) | ||
| Non-cash investing and financing activities: | ||
| Changes in the fair value of the stock warrant liability and stock tranche option liability | ||
| Operating lease right-of-use assets exchanged for lease liabilities | ||
| Purchases of property and equipment, accrued but not yet paid | ||
| Reconciliation of cash and cash equivalents and restricted cash: | ||
| Cash and cash equivalents | ||
| Restricted cash included in prepaids and other current assets |
Loading...